Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00565669 · ClinicalTrials.gov registry record · NA
Evaluation of Blink Tears and Systane Concomitant With Restasis for the Treatment of Dry Eye Symptoms
A NA study, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT00565669 is a NA study that has completed, run by Medical University of South Carolina. The registered enrollment target is 20 participants.
The verdict
NCT00565669, a NA study, has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the efficacy of Blink Tears and Systane used concomitantly with topical cyclosporine for the treatment of dry eye.
Interventions
- DRUG Systane
- DRUG Cyclosporin A Restasis®
- DRUG Blink tears
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2007-10 |
| Est. Completion | 2008-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00565669
The ClinicalTrials.gov registry entry for NCT00565669 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Systane is the first listed.
NCT00565669 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00565669 about?
NCT00565669 is a clinical study titled "Evaluation of Blink Tears and Systane Concomitant With Restasis for the Treatment of Dry Eye Symptoms". The purpose of this study is to evaluate the efficacy of Blink Tears and Systane used concomitantly with topical cyclosporine for the treatment of dry eye.
What is the current status of trial NCT00565669?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2007-10. Estimated completion is 2008-10.
What interventions are being tested in trial NCT00565669?
The interventions under investigation include: Systane (DRUG), Cyclosporin A Restasis® (DRUG), Blink tears (DRUG).
Who is sponsoring clinical trial NCT00565669?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.